Nano Nuclear Energy shares tumbled 26.6% during December, driven by the company’s continued lack of revenue and escalating cash burn. In the trailing twelve months ending in December, free cash flow stood at negative $37 million, and no microreactor design has yet received Nuclear Regulatory Commission approval. Since its IPO in mid-2024, the share count has climbed by 77%, primarily through equity issuances to fund operations, creating significant dilution pressure on future earnings per share and free cash flow per share. The market capitalization, which reached approximately $1.6 billion earlier in the quarter, reflects investor skepticism about the company’s path to commercialization and sustained profitability.

On January 5, Nano Nuclear Energy stock surged 13.5% in response to reports that the U.S. House Energy Subcommittee will hold hearings this year on small modular reactors and potential regulatory relief measures. Congressional attention echoes executive orders mandating three experimental reactors by July 4, 2026, SMR deployments by the end of 2027, and at least one reactor on a military base by 2028. Despite the optimism, analysts surveyed by S&P Global Market Intelligence rate Nano Nuclear as the weakest among the three leading SMR developers, forecasting growing annual losses through 2031 before a projected turnaround to $5.70 in earnings per share by 2033—an outcome many consider unlikely without significant technological or regulatory breakthroughs.